Artwork for podcast A Virtual View
Remote Patient Monitoring with Mark Russell and Janson Lanier
Episode 1516th September 2022 • A Virtual View • Upper Midwest Telehealth Resource Center
00:00:00 00:28:57

Share Episode

Shownotes

Danielle speaks with Mark Russell and Janson Lanier from Vitalograph about Remote Patient Monitoring (RPM) and Respiratory Diagnostics. Tune in for an overview of specialty RPM devices and a discussion of how they can be used to monitor chronic and acute conditions.

Transcripts

Danielle Renckly:

Welcome to a virtual view.

Danielle Renckly:

A telehealth podcast brought to you by the upper Midwest telehealth resource center.

Danielle Renckly:

This is Danielle ley, your host.

Danielle Renckly:

And today I am joined by Mark Russell and Jansen Lanier from bat Telegraph.

Danielle Renckly:

Thank you so much for being here today.

Mark Russell:

Thank you for inviting us.

Danielle Renckly:

Could you both tell me a little about yourselves?

Mark Russell:

I'm Mark Russell.

Mark Russell:

I'm the marketing communications manager for vital Telegraph.

Mark Russell:

I've been with the company for five years.

Mark Russell:

I've been in healthcare for over 25 years and I joined the company.

Mark Russell:

At a really really exciting time right before COVID at least a year and a half.

Mark Russell:

We were involved in lots of conferences and trade shows

Mark Russell:

and then basically COVID hit.

Mark Russell:

And we had to transition a lot of our marketing strategy to be more remote.

Mark Russell:

And and this year we've got a plethora of new products that

Mark Russell:

we're getting ready to launch.

Mark Russell:

Yep.

Mark Russell:

And I'm Jan Lanier national sales manager, respiratory therapist for vital Telegraph.

Mark Russell:

I've been in respiratory sleep diagnostics since 2006.

Mark Russell:

In every capacity you could think of for a couple different companies.

Mark Russell:

I joined vital Telegraph three years ago this week.

Mark Russell:

And like mark was mentioning lot of transitions and changes in.

Mark Russell:

Just from the view of the company to how do you change the outlook

Mark Russell:

of what you're doing on a day to day basis because of the pandemic?

Danielle Renckly:

So tell me a little bit more about VI Telegraph.

Danielle Renckly:

What do you

Mark Russell:

The Telegraph products and services are chosen

Mark Russell:

by medical professionals over 113 countries for healthcare,

Mark Russell:

occupational and clinical trials.

Mark Russell:

We manufacture and supply quality spirometry and respiratory

Mark Russell:

medical devices, which are.

Mark Russell:

Used as a to detection and diagnosis and control of respiratory conditions.

Mark Russell:

We also deliver successful clinical trials for many of the world

Mark Russell:

leading phar world leading pharmacy, pharmaceutical companies, biotech,

Mark Russell:

and contracted research organizations.

Mark Russell:

Right now we have probably over 69 live Clinical trials worldwide.

Mark Russell:

Yeah.

Mark Russell:

I like to say, we started in 1960s as a respiratory diagnostic company, we were

Mark Russell:

in Occupational health is where we got started and branched out from there.

Mark Russell:

When I say respiratory diagnostics, it is everything from occupational

Mark Russell:

health to primary, secondary health, even into clinical trials.

Mark Russell:

So we basically provide.

Mark Russell:

The assistance to staff to help diagnose respiratory illnesses.

Mark Russell:

And we're based in the UK.

Mark Russell:

That's where our corporate we're family owned company.

Mark Russell:

And we have offices in Germany, Japan, and of course here in the us, our

Mark Russell:

devices are manufactured in Ireland.

Danielle Renckly:

Wow.

Danielle Renckly:

Working from multiple countries.

Danielle Renckly:

Sounds just a massive undertaking, like the U T.

Danielle Renckly:

We operate in four states.

Danielle Renckly:

And I know that even for us, like time zones are incredibly annoying.

Danielle Renckly:

So I'm sure that coordination and planning is really important

Danielle Renckly:

to make sure everyone's on the

Mark Russell:

Absolutely.

Mark Russell:

We're working with six and seven hour differences for meetings.

Mark Russell:

So we'll have something at 7:00 AM and it's their 3:00 PM, for their time,

Mark Russell:

they're getting ready to finish their day.

Mark Russell:

We're not even in the office yet.

Mark Russell:

So it's just those things that you have to logistically deal with.

Mark Russell:

But I think that we all work pretty well together.

Mark Russell:

As a company, whole because we have one goal, one mission and that's to

Mark Russell:

bring integrity to to the industry.

Danielle Renckly:

It's pretty cool.

Danielle Renckly:

So I have done the requisite amount of Googling over respiratory devices, cuz

Danielle Renckly:

I am not a medical professional in that sense, but I'm sure you could give a much

Danielle Renckly:

more succinct explanation of what exactly they are and what they do than I could.

Danielle Renckly:

So I will leave that

Mark Russell:

Respiratory diagnos.

Mark Russell:

Devices, basically they help diagnose everything from asthma to cystic

Mark Russell:

fibrosis, pulmonary fibrosis, you can be used to help identify,

Mark Russell:

cancer screenings, things like this.

Mark Russell:

And it's across the board.

Mark Russell:

It goes everywhere from.

Mark Russell:

Your home monitoring systems that are basically handheld pieces that people

Mark Russell:

take a deep breath in and blow into.

Mark Russell:

But overall respiratory diagnostics is lung function, right?

Mark Russell:

It's basically how the lungs are doing.

Mark Russell:

And is there any restrictions in the lungs?

Mark Russell:

So a patient can come in and do what we consider a maneuver or a.

Mark Russell:

They take a deep breath in and blow really hard.

Mark Russell:

Almost like you're doing a breathalyzer.

Mark Russell:

I hope none of you have done breathalyzers, but if you have you

Mark Russell:

get the idea, you've seen it on TV.

Mark Russell:

But it's also even as far as breaking it down for inhaler use.

Mark Russell:

So you know that people are diagnosed inhalers for any respiratory illnesses.

Mark Russell:

Whether it's allergies during, the fall and the spring or it's upper

Mark Russell:

respiratory infection, you get an.

Mark Russell:

We have a device, that tracks that to make sure people are utilizing the inhaler

Mark Russell:

properly, getting the amount of medication they need because far too often a, an

Mark Russell:

inhaler is prescribed and the pharmacist.

Mark Russell:

Oh, do you know how to use an inhaler?

Mark Russell:

Oh yeah, of course.

Mark Russell:

Whatever.

Mark Russell:

Guess what?

Mark Russell:

More than likely they're not doing it.

Mark Russell:

Correct.

Mark Russell:

The device basically helps you walk through the typing mechanisms or if it's a

Mark Russell:

dry, powdered inhaler, making sure you're forcing, inhale fast enough and so forth.

Mark Russell:

So it's little things like this that we work with throughout either

Mark Russell:

pharmacy primary care, secondary care allergy asthma clinics.

Mark Russell:

I even said we work with occupational health

Danielle Renckly:

Gotcha.

Danielle Renckly:

So generally these are gonna be used for more chronic conditions.

Mark Russell:

possibly.

Mark Russell:

Yeah.

Mark Russell:

Yep.

Danielle Renckly:

Yeah.

Danielle Renckly:

Okay.

Danielle Renckly:

These devices, you mentioned briefly that some of them do function as

Danielle Renckly:

remote patient monitoring devices.

Mark Russell:

Absolutely.

Mark Russell:

So we've had remote patient monitoring devices for quite

Mark Russell:

some time in the late nineties.

Mark Russell:

So they've been around for a long time.

Mark Russell:

What hasn't happened until the pandemic was it wasn't really

Mark Russell:

being adopted at a hospital level.

Mark Russell:

It was more of the.

Mark Russell:

practice and allergy asthma care centers would provide a lung monitor that would

Mark Russell:

basically just track the patient post lung transplant or post asthma diagnosis.

Mark Russell:

But what happened is that when the pandemic came along remote

Mark Russell:

patient monitoring became a need.

Mark Russell:

Before it was a luxury.

Mark Russell:

Now it's a need.

Mark Russell:

And so now we're moving into the next stages of what are we doing

Mark Russell:

to track set patients post COVID.

Mark Russell:

Pulmonary fibrosis, post lung transplant patients and so forth.

Mark Russell:

We're working with a lot of different three PIs, which are third party

Mark Russell:

integrators that have apps for iPhones and Samsung, galaxy or whatever the

Mark Russell:

Google play, that, whatever newest applications there are out there.

Mark Russell:

Working with those guys to ensure that we're bringing the right options to the.

Danielle Renckly:

Yeah.

Danielle Renckly:

RPM is a, just a massive market right now.

Danielle Renckly:

I think it's something like 14 million users in the us alone,

Danielle Renckly:

and I know it's expected to grow and just continue to grow.

Mark Russell:

Attended the American telehealth association this year in may.

Mark Russell:

And it was the first time that we had attended the live show and so many big

Mark Russell:

companies there that are looking at remote patient monitoring which naming Amazon

Mark Russell:

Walmart they are all out there looking at for opportunities to help improve.

Mark Russell:

He.

Mark Russell:

Yeah.

Mark Russell:

When it comes to remote patient monitoring a lot of times it has been pulse Sox,

Mark Russell:

imagery things like this, the basics weight, scale temperature, things that

Mark Russell:

have been tying into an application.

Mark Russell:

Now it's gotten so far as they want respiratory rate, they want

Mark Russell:

FEV one and peak flow and so forth that are coming across.

Mark Russell:

So you can track true respiratory related in illnesses.

Mark Russell:

That's why since the pandemic that has come on quite strong, so respiratory

Mark Russell:

remote monitoring has been, or remote respiratory monitoring has

Mark Russell:

been quite popular the last two.

Danielle Renckly:

Oh, I'm sure.

Danielle Renckly:

And obviously it's not ideal for every device.

Danielle Renckly:

Some do need like a medical professional

Mark Russell:

Oh, yeah, absolutely.

Mark Russell:

Absolutely.

Mark Russell:

So there is, so that's exactly why we call it a monitor instead of a spirometer

Mark Russell:

is something that they do in the lab with a technician that, that coaches

Mark Russell:

them to do a proper and maneuver.

Mark Russell:

It's it's like when you're lifting weights and you're pushing hard.

Mark Russell:

But when you have a coach over there trying to push you even harder and harder,

Mark Russell:

you're gonna actually get that weight up.

Mark Russell:

So imagine blowing out as hard as you can.

Mark Russell:

If you have a coach sitting next to you or talking to you over telehealth.

Mark Russell:

They're blowing it through.

Mark Russell:

They're telling you go.

Mark Russell:

You're gonna get more of an effort to get better numbers.

Mark Russell:

When we do the remote patient monitoring, when it's just a patient at home,

Mark Russell:

they're gonna get solid results, but they're just a monitor so they

Mark Russell:

can tell their day to day numbers.

Mark Russell:

If they start to decline or a trend of declining, they know that

Mark Russell:

they can come into the, to the hospital and do a full workup.

Danielle Renckly:

right.

Danielle Renckly:

And that's good from the sense of we're saving the effort of those

Danielle Renckly:

patients having to come in every day and get tested, but there's still.

Mark Russell:

Especially during the pandemic when people are afraid.

Mark Russell:

I promise you, people are still on that leery edge, imagine first wave

Mark Russell:

COVID patients they were feeling ill.

Mark Russell:

They come in, they get diagnosed with COVID they're in the hospital for two

Mark Russell:

weeks, three weeks, whatever it may be.

Mark Russell:

And then all of a sudden they're discharge.

Mark Russell:

They're still having symptoms, but they're afraid to come back.

Mark Russell:

They're afraid to say anything because they don't want to be in the same boat.

Mark Russell:

They just.

Mark Russell:

Okay.

Mark Russell:

So we want to try to capture those patients again, to continue

Mark Russell:

to make sure they're doing okay.

Mark Russell:

And I've had this discussion with pulmonologists all across the country

Mark Russell:

on follow up post COVID follow up.

Mark Russell:

What are you doing?

Mark Russell:

How are you making sure those patients are really taken care of.

Mark Russell:

And honestly, majority of the docs that I talked to said, there's not

Mark Russell:

enough time in a day for them to follow up with as many patients that came.

Mark Russell:

So it's one of those where we have to put more focus on it, or even put

Mark Russell:

the hospital systems more unchecked to get those patients checked.

Danielle Renckly:

Oh, for sure.

Danielle Renckly:

And I'm sure when we talk about quote unquote long COVID,

Danielle Renckly:

it's gonna continue to be

Mark Russell:

Absolutely.

Mark Russell:

It comes more prevalent than we know.

Mark Russell:

Because of the people that don't wanna say anything, there, there are patients

Mark Russell:

that I talk to on, on a frequently basis that they're saying they struggle

Mark Russell:

going up and down stairs when they're talking about six or seven stairs.

Mark Russell:

I'm like, have you talked to your doctor about it?

Mark Russell:

Not really.

Mark Russell:

I just, I don't wanna bother cuz it's not that bad.

Mark Russell:

That's the only time it happens.

Mark Russell:

Is it the only time?

Mark Russell:

How do you know if you're not just walking down the hallway and you're

Mark Russell:

getting breath, or what happens if something else is not going to work as

Mark Russell:

properly, if you don't get that Lu lung function going, if you're not using

Mark Russell:

your lungs, then everything suffers.

Mark Russell:

So

Danielle Renckly:

oh, for sure.

Danielle Renckly:

so I know that innovation is an important aspect of what you do

Danielle Renckly:

as well as an important aspect of just healthcare in general.

Danielle Renckly:

So how do you think that innovation will impact healthcare in the

Mark Russell:

think two words go together, innovation and evolving.

Mark Russell:

You have to evolve.

Mark Russell:

So if you look at, like I had mentioned if you came in.

Mark Russell:

To see vital Telegraph's business plan prior to the pandemic it is completely

Mark Russell:

180, it completely different direction.

Mark Russell:

But by doing so we've figured out what.

Mark Russell:

What is needed in the field, by us going out there and having customers that are

Mark Russell:

telling us, Hey, this is what we need.

Mark Russell:

This is how we need to evolve into the new healthcare.

Mark Russell:

So we bring the innovations to them.

Mark Russell:

They tell us what we need.

Mark Russell:

We put it on paper, we develop it and really release it.

Mark Russell:

So last year we introduced a new device this year.

Mark Russell:

We have four devices that we're introducing.

Mark Russell:

We just released one.

Mark Russell:

We're getting ready to release three more here at the end of the year.

Mark Russell:

So it's one of those where we have heard everything that's needed.

Mark Russell:

We are going to market with products that have been asked for.

Mark Russell:

And updated with the ATS standards.

Mark Russell:

Yes.

Mark Russell:

So 2019 ATS S came out with new standards for barometry, which they

Mark Russell:

hadn't been changed since 2005.

Danielle Renckly:

oh, wow.

Mark Russell:

Yeah, 14 years of change in healthcare.

Mark Russell:

If you can think of how you changed in 14 years.

Mark Russell:

I know I changed a lot.

Mark Russell:

Mark's the same guy as he is always been.

Mark Russell:

So but yes so the change that came was very much needed.

Mark Russell:

And as a manufacturer, you see these changes and you're

Mark Russell:

like, okay, let's grab it.

Mark Russell:

Let's make the adjustments and release products because we want.

Mark Russell:

Our end users the customers, the hospital systems, the doctor's offices

Mark Russell:

to have everything at their hands that's compliant as well as give the

Mark Russell:

options for the patients to, to have the tools available, to get better.

Mark Russell:

It's all about patient care.

Mark Russell:

Everybody wants to talk insurances and payments and whatever like that.

Mark Russell:

No it's about patient care.

Mark Russell:

It should always be about patient care.

Danielle Renckly:

and in the realm of patient care, I'd be interested in looking

Danielle Renckly:

at how medical devices, including like these respiratory diagnostic devices

Danielle Renckly:

could be used more as preventative care, at least early warning systems.

Mark Russell:

percent.

Mark Russell:

Yeah.

Mark Russell:

I think the pandemic has really opened up healthcare in a lot of different ways

Mark Russell:

because in one, one way it put a strain on In a sense that we had so many patients,

Mark Russell:

but in the other, it opened up other opportunities like pharmacies being more,

Mark Russell:

a part of the team and healthcare used to be, you just got your prescription

Mark Russell:

now, you get your shots and and.

Mark Russell:

There are some pharmacies that are doing spirometry.

Mark Russell:

Yep.

Mark Russell:

The mini clinics as well.

Mark Russell:

And so basically I think that because of this pandemic, there's a lot of good

Mark Russell:

things that have come out on it, test the system and open up our opportunities

Mark Russell:

in different industries to help the system because we've got, shortages.

Mark Russell:

We had shortage of nurses and respiratory therapists before this pandemic.

Mark Russell:

Now it's even worse.

Mark Russell:

It's even worse.

Mark Russell:

So I think you, you really hit it on the head Danielle

Mark Russell:

with, the preventative piece.

Mark Russell:

We really have been a reactive culture, if you will.

Mark Russell:

Not just in healthcare, but in the United States we're a reactive group.

Mark Russell:

But being more preventative on healthcare in general, whether it's with diabetic

Mark Russell:

patients or, whatever it may be.

Mark Russell:

It's not just a respiratory thing, but I think the pandemic

Mark Russell:

made light even more of.

Mark Russell:

Your preexisting injuries were preexisting illnesses or anything like that.

Mark Russell:

I think that we need to get back to healthy life develop instead of reactive.

Danielle Renckly:

And I do like earlier, how you said mark, about how it put

Danielle Renckly:

a strain on our healthcare system.

Danielle Renckly:

And I think while it did identify a lot of weaknesses that do exist, it

Danielle Renckly:

also identified a lot of areas for opportunity and a lot of areas for growth.

Danielle Renckly:

And I think RPM devices and just respiratory devices in general, there

Danielle Renckly:

was probably a lot of that there.

Danielle Renckly:

So we talked earlier about innovation.

Danielle Renckly:

So would you say telehealth is going to be part of that healthcare innovation in the.

Mark Russell:

I agree a hundred percent.

Mark Russell:

I think that going back to payers are gonna actually be putting more emphasis

Mark Russell:

on telehealth as your first line.

Mark Russell:

Instead of the patients coming into the office, they're gonna do a telehealth

Mark Russell:

visit to isolate what needs to come in the urgency of how bad it is and so forth.

Mark Russell:

I know that with our insurance, we can call doctors on demand and it's a free

Mark Russell:

service for us through our insurance.

Mark Russell:

Doctors on demand will do that triage appointment to see how severe it is.

Mark Russell:

And if it is severe, more severe than they're able to handle, they'll make

Mark Russell:

you a, an appointment with a local P.

Mark Russell:

I think also they also have other features such as they, they track a

Mark Russell:

lot of your your medical journey with physicals and screenings and such.

Mark Russell:

And they reward you with that.

Mark Russell:

Our insurance company gives points out, which you can re.

Mark Russell:

For gift certificates and such.

Mark Russell:

I have a Fitbit that I didn't think I'd ever had before, and it monitors

Mark Russell:

all my steps and I, basically utilize that as to, to be more healthier.

Mark Russell:

And then also it's an incentivizer for the gift certificates and I can

Mark Russell:

see telehealth doing the same thing in the future with our monitors and

Mark Russell:

such as the payers see the benefit.

Danielle Renckly:

Yeah, I think that's great from an standpoint

Danielle Renckly:

of health literacy as well.

Danielle Renckly:

Just understanding more about your own health.

Danielle Renckly:

Cause I know that's something that you would think people would be aware of their

Danielle Renckly:

own health, but really that's not the.

Danielle Renckly:

But innovation in telehealth, like we talked about, it's something that

Danielle Renckly:

I'm really passionate about from a standpoint of health, equity and access.

Danielle Renckly:

Like when we look about specialized care, like what you do with respiratory

Danielle Renckly:

diagnostic devices, that's something that can be inaccessible to folks who are

Danielle Renckly:

for whatever reason, unable to travel.

Danielle Renckly:

And that's everyone from aging populations who just are not able to travel

Danielle Renckly:

anymore or to rural populations where travel would just be unfeasibly long.

Danielle Renckly:

But we look at telehealth and RPM devices, and I think it's really promising from

Danielle Renckly:

the standpoint of access and getting folks just access to specialized

Danielle Renckly:

care that they might not have other.

Mark Russell:

Yeah.

Mark Russell:

We work with a few programs that actually do a lot of rural health screenings.

Mark Russell:

And so instead of actually sending somebody out on site to do a house

Mark Russell:

visit, they'll send a box of.

Mark Russell:

RPM devices.

Mark Russell:

Usually it's a blood pressure cuff.

Mark Russell:

It's a SPO two weight scale respiratory monitor and thermometer.

Mark Russell:

Okay.

Mark Russell:

So you do all those screenings and then they'll have a telehealth visit once

Mark Russell:

you've done those screenings in that day.

Mark Russell:

And it's pretty solid.

Danielle Renckly:

no, that's awesome.

Danielle Renckly:

From an access standpoint, I think so to go off topic a little bit.

Danielle Renckly:

This is something you mentioned earlier that I wanted to touch on.

Danielle Renckly:

I know that interoperability can be a challenge when working with

Danielle Renckly:

medical devices and like data systems.

Danielle Renckly:

Is that something you have to contend with in your work?

Mark Russell:

Yeah.

Mark Russell:

Yes.

Mark Russell:

It's one of those where we work with either the third party

Mark Russell:

integrators or working with the EMR systems and trying to get those

Mark Russell:

involved for formal communication.

Mark Russell:

But overall it's gotten a lot better than it has say, even five years ago.

Mark Russell:

Where at one point wifi and Bluetooth technology was shunned upon.

Mark Russell:

It was one of those where we can't control the data that comes across,

Mark Russell:

but Bluetooth technology and wifi technology has gotten so strong with

Mark Russell:

the securities that it groups are just asking, what's your wifi picture, if you

Mark Russell:

will, or what's your Bluetooth protocols.

Mark Russell:

And as soon as they see those.

Mark Russell:

They are putting the stamp of approval and moving it on to the next stage.

Mark Russell:

I promise you, five years ago, you come in and say, Hey, this is a wifi device.

Mark Russell:

Sorry.

Mark Russell:

We're not a wifi center.

Mark Russell:

And we partnered we noticed at ATA we partnered with about five

Mark Russell:

different companies that have apps.

Mark Russell:

Phillips is one of them and they've been around for a long time in medical field

Mark Russell:

and very lead the way and in technology.

Mark Russell:

And they have their own health.

Mark Russell:

Program we've worked with other companies such as vital flow and pull, manage.

Mark Russell:

They all have apps that are secure and have their specific information

Mark Russell:

that they're pulling from for whatever diagnostic they need for respiratory.

Mark Russell:

Yep.

Danielle Renckly:

Gotcha.

Danielle Renckly:

. And so what do you think the future of RPM and diagnostic devices as

Danielle Renckly:

well as telehealth and that kind of thing in general might look.

Mark Russell:

Oh, I think that technology such as this Fitbit, 10 years ago, wasn't.

Mark Russell:

Existence little company called Garin over here started here in

Mark Russell:

Kansas city has grown very vastly.

Mark Russell:

And I think that the technology in healthcare is gonna go right along with

Mark Russell:

it, with the apple watches and such.

Mark Russell:

I think that eventually we'll have monitoring.

Mark Russell:

On a daily basis.

Mark Russell:

Yeah.

Mark Russell:

And it'll be connected with a healthcare professional and we will have, daily

Mark Russell:

information going into them and then we'll be checking it probably in a hub center.

Mark Russell:

And it will go to your primary care doctor and keep you keeping posted

Mark Russell:

on, whatever element you may be having or could have in the future.

Mark Russell:

I think it, it may be even going a little further in the fact that a lot of.

Mark Russell:

Clinical time was in sleep medicine.

Mark Russell:

So it went from people going into a sleep lab, doing an overnight sleep study

Mark Russell:

to people doing home, sleep testing.

Mark Russell:

Okay.

Mark Russell:

So home sleep testing, they have a device they wear at home it's been delivered

Mark Russell:

to them or they go in and pick it up.

Mark Russell:

But I feel like respiratory diagnostics, maybe going this direction, where prior to

Mark Russell:

you coming into the lab and doing a full workup, we're gonna do a precursor test

Mark Russell:

on a lung monitor, whatever it may be just as a, give me a snapshot of your lung.

Mark Russell:

And this is, this could become a requirement by insurances like HST home

Mark Russell:

food testing is for sleep medicine.

Mark Russell:

So I see that this could be the way that insurance pushes

Mark Russell:

it, but also I see that as.

Mark Russell:

Know, the pandemic slows down and increases slows down and increases.

Mark Russell:

It's just one of those things that I don't feel like it's going away.

Mark Russell:

Yeah.

Mark Russell:

The future is gonna continue and we're gonna be more innovative on our offerings.

Mark Russell:

More streamlined, more cost effective as these things come out.

Mark Russell:

I think so.

Mark Russell:

I think with our air quality, is very questionable, in the future

Mark Russell:

asthma and C O P D on a rise.

Mark Russell:

You just, we've got the baby boomers on the end are really

Mark Russell:

getting hit hard on C O P D.

Mark Russell:

It's gonna be something that's gonna be a necessity.

Danielle Renckly:

I always like asking this question about future of

Danielle Renckly:

healthcare, because even with folks in very similar fields, you tend

Danielle Renckly:

to get really different answers.

Danielle Renckly:

The future of healthcare and technology in healthcare specifically is

Danielle Renckly:

something like that's just so broad.

Danielle Renckly:

And we talk about increased connectivity and more accurate and reliable technology.

Danielle Renckly:

And I.

Danielle Renckly:

That'll be great for all fields of healthcare in just so many different

Danielle Renckly:

ways that you could take a whole day and you wouldn't be done talking about it.

Mark Russell:

You get five people from five different healthcare industries and

Mark Russell:

talk about innovations that are coming out and talk about, oh, that's fantastic.

Mark Russell:

We should have thought about that as a market strategy or something

Mark Russell:

like that, which is fantastic.

Mark Russell:

I don't know why we don't do these more often as a manufacturer.

Mark Russell:

I would love to sit with other manufacturers outside of just

Mark Russell:

respiratory, but in other areas and say, Hey, how can we all come together?

Mark Russell:

For one global mission.

Danielle Renckly:

Yeah.

Danielle Renckly:

And it's yeah.

Danielle Renckly:

It's like the invention of calculus.

Danielle Renckly:

A lot of the time where you've got like a bunch of different people who are

Danielle Renckly:

probably inventing the same thing, even though they're working independently.

Danielle Renckly:

But I always think that's interesting how folks are coming up with all these

Danielle Renckly:

different solutions for the same problems and addressing them in the different ways.

Danielle Renckly:

Yeah.

Danielle Renckly:

But I know you guys have a podcast as well.

Danielle Renckly:

Could you tell me a

Mark Russell:

We do.

Mark Russell:

Yeah, because of the pandemic.

Mark Russell:

We had to switch our, like I said earlier our marketing strategy and we

Mark Russell:

wanted to become more of a resource.

Mark Russell:

Our website is visited all over the world.

Mark Russell:

A lot of.

Mark Russell:

Great information on respiratory diagnostic and white papers and such.

Mark Russell:

So we developed a program where we have webinars that are C E approved by

Mark Russell:

arc for information out there on, on respiratory diagnostics and other issues.

Mark Russell:

And and then we developed a podcast.

Mark Russell:

Our podcast is called exhale.

Mark Russell:

With vital Telegraph, it's on all the platforms.

Mark Russell:

And again, it's just a resource of information.

Mark Russell:

We've had physicians on there that have written books to a respiratory therapist

Mark Russell:

to tell us about last year, about their day at in the hospital with COVID.

Mark Russell:

Yeah, that's one of my most proud features that we had of the podcast.

Mark Russell:

It was the follow the respiratory therapist and it was a.

Mark Russell:

Four or five part series where we talked to a director of respiratory

Mark Russell:

and ER, direct, ER, respiratory therapist travel a traveling therapist

Mark Russell:

as well as a ICU therapist during COVID and what their daily, routine

Mark Russell:

looked like and the burnout rate.

Mark Russell:

And it was just one of those raw.

Mark Russell:

Emotional times that I felt really compelled to get the message out.

Mark Russell:

And I still feel that way.

Mark Russell:

And when mark says resources, I am big since the pandemic is that

Mark Russell:

people don't want somebody to come in and sell them something.

Mark Russell:

Okay.

Mark Russell:

They don't want a rep to come in and say, Hey, or buy my product

Mark Russell:

because you need this product.

Mark Russell:

Guess.

Mark Russell:

Let's be a resource.

Mark Russell:

Let's be a resource for each other to grow.

Mark Russell:

Okay.

Mark Russell:

Whether I help you with something here, or if I put a, a.to dot connection

Mark Russell:

that this is a resource for you.

Mark Russell:

So with the podcast, it is across the board, respiratory related.

Mark Russell:

But it is, it could be an advertisement for a product.

Mark Russell:

It can be just a story of how somebody came from this point.

Mark Russell:

To this point.

Mark Russell:

It could be anything respiratory related, but I can promise you out of the 30 or so

Mark Russell:

podcast that we've done, anyone can find one of the subjects that they tie to.

Mark Russell:

That really relates to what their everyday life is.

Mark Russell:

And I want to continue that and I look for different podcasts and mark looks

Mark Russell:

for different podcasts on a daily basis.

Mark Russell:

We'll see somebody on LinkedIn that shares a message.

Mark Russell:

Facebook, Twitter.

Mark Russell:

Last one was TikTok.

Mark Russell:

There's a young lady that does, that has CF and she does her daily.

Mark Russell:

TikTok for CF and talks about her journey.

Mark Russell:

It's fantastic in, in really motivating and I love that story.

Mark Russell:

So it's one of those, we're gonna get a podcast with her later this year.

Mark Russell:

These are the people that I want to talk to and just like your group too.

Mark Russell:

These are pieces that I love to share with, and I never realized how much.

Mark Russell:

We would enjoy doing podcasts, but we really do.

Mark Russell:

If you go back to episodes, one, two, and three, we are raw.

Mark Russell:

Yeah, it is.

Mark Russell:

It's ugly, raw.

Mark Russell:

And I know you guys can attest, but it was a microphone and that was about it.

Mark Russell:

And we did our own.

Mark Russell:

And then we had a partner that we got in with that could do the

Mark Russell:

editing and Jade does a fantastic job with that and cleans it all up.

Mark Russell:

And we had a, we had just a share quick note.

Mark Russell:

We had a podcast with a a woman in Uganda and they Of course, you wanna

Mark Russell:

make sure you're in a secure, quiet room?

Mark Russell:

She had a rooster in the background and that rooster was growing about

Mark Russell:

two or three times during our interview and our editor sure.

Mark Russell:

Had a hard time editing that out.

Mark Russell:

Just like at first we had identify it.

Mark Russell:

It's what is that?

Mark Russell:

What is that sounded like a Kyle for a minute.

Mark Russell:

It was like, okay It happened to be just a rooster, but it was one of those amazing

Mark Russell:

things that they could edit it out.

Mark Russell:

And then time difference, it was early in the morning here

Marni:

technology

Mark Russell:

and in Uganda, it was late evening when rooster were.

Danielle Renckly:

no, that's incredible.

Danielle Renckly:

And I do like how you touch on how social media and.

Danielle Renckly:

Just connective platforms that we didn't have 20, 30 years ago are just helping

Danielle Renckly:

folks from all sorts of professions.

Danielle Renckly:

Just connect and share information.

Danielle Renckly:

I think that's so

Mark Russell:

I'll be honest.

Mark Russell:

When we first started the podcast, we only had LinkedIn is what we were doing.

Mark Russell:

We had Twitter, but we just weren't actively doing anything with it.

Mark Russell:

No Facebook, nothing else.

Mark Russell:

It became one of those places where we could expand out to and.

Mark Russell:

Even if it's just a post it's nothing, it's just a post, but it happened to be

Mark Russell:

reaching a lot more people than we expect.

Mark Russell:

They were sharing it and so forth and it meant a lot.

Mark Russell:

So we continued with that avenue.

Mark Russell:

I could see us doing, maybe not TikTok, but just, you know what I'm saying?

Mark Russell:

It's I would rather see mark do some nice dances and not at all.

Danielle Renckly:

me know.

Danielle Renckly:

I'll watch

Mark Russell:

My dancing days are over with, but yeah, it's, basically

Mark Russell:

it has grown and I'm sure you've seen the same thing in the last six months.

Mark Russell:

We, it took us a year to get so many downloads and in the last

Mark Russell:

six months we've doubled it.

Mark Russell:

And it's only.

Mark Russell:

Because of content, you have to get good content and interesting

Mark Russell:

guess, and it is a challenge.

Mark Russell:

And we like, I, like Janssen said, we get it from a lot of social media posts.

Mark Russell:

We've run into a couple of doctors uh, a doctor and a respiratory

Mark Russell:

therapist, a doctor who has a book.

Mark Russell:

Called exhale.

Mark Russell:

And and so we interviewed him, he was a transplant doctor and he

Mark Russell:

wanted to share his experiences with the challenges of transplant.

Mark Russell:

And then we just interviewed just recently a young lady that

Mark Russell:

has a website called exhale.

Mark Russell:

And it is a it's a respiratory.

Mark Russell:

It was a website where it's a training program training program for

Mark Russell:

respiratory therapy outta Oklahoma city.

Mark Russell:

Yep.

Mark Russell:

And and such, so its a popular name and I'm glad I picked it.

Mark Russell:

So I'm just waiting for Jada pig Smith and queen Latifa

Mark Russell:

from waiting to exhale to call.

Danielle Renckly:

You guys are the exhale family.

Danielle Renckly:

oh, I love it.

Mark Russell:

digress.

Mark Russell:

So again it's exhale with VI Telegraph.

Danielle Renckly:

Thank you so much for joining us today on a virtual view.

Danielle Renckly:

I think we had a great conversation.

Danielle Renckly:

I really appreciate you both taking the time to be here today.

Mark Russell:

that's great.

Mark Russell:

Thanks.

Mark Russell:

Thanks for inviting us.

Mark Russell:

Thanks.

Danielle Renckly:

Yeah, of course.

Caroline Yoder:

Thank you for listening to a virtual view.

Caroline Yoder:

You can find more information about today's episode in the show notes below.

Caroline Yoder:

If you would like to support our podcast, please rate and review us

Caroline Yoder:

on your favorite podcast player.

Caroline Yoder:

Do you have any questions or topics you'd like us to discuss?

Caroline Yoder:

If so, contact us at info at UMTRC dot org or through the

Caroline Yoder:

form found in the show notes.

Caroline Yoder:

Also, we'd like to give a special thanks to our editor.

Caroline Yoder:

Finally a special thanks to the health resources and service administration.

Caroline Yoder:

Also known as HERSA.

Caroline Yoder:

Our podcast series of virtual view is sponsored in part by hearses telehealth

Caroline Yoder:

resource center program, which is under hers is office of the administrator and

Caroline Yoder:

the office for the advancement of tele.

Caroline Yoder:

The content and conclusions of this podcast are those of the UMTRC and

Caroline Yoder:

should not be construed as the official policy of, or the position of nor

Caroline Yoder:

should any endorsements be inferred by HERSA, HHS, or the U S government.

Caroline Yoder:

Thanks for listening and have a . Great day.

Follow

Chapters

Video

More from YouTube